老年肺部感染住院患者给予头孢哌酮舒巴坦经验性治疗联合血必净辅助治疗的效果  

Effect of empirical treatment of cefoperazone sulbactam combined with Xuebijing injection in elderly patients with pulmonary infection

作　　者：苏海燕 SU Hai-yan(Department of Geriatrics, Nuclear Industry 215 Hospital of Shaanxi Province, Xianyang 712000, China)

机构地区：[1]陕西省核工业二一五医院老年病科,陕西咸阳712000

出　　处：《中国生化药物杂志》2017年第12期347-348,共2页Chinese Journal of Biochemical Pharmaceutics

摘　　要：目的探讨老年肺部感染住院患者给予头孢哌酮舒巴坦经验性治疗联合血必净辅助治疗的临床效果。方法选取2016年6月～2017年8月陕西省核工业二一五医院住院收治老年肺部感染患者78例，随机分为研究组（头孢哌酮舒巴坦经验性治疗+血必净辅助治疗）和对照组（头孢哌酮舒巴坦经验性治疗），每组39例。比较2组患者疗效、治疗前后炎症指标及不良反应发生率。结果研究组患者疗效显著高于对照组（P＜0.05）。2组患者头晕、胃肠不适、皮疹、肝功能损伤、肾功能损伤发生率比较差异无统计学意义。结论老年肺部感染住院患者给予头孢哌酮舒巴坦经验性治疗，配合血必净辅助治疗，可显著提高患者临床疗效，并不增加药物不良反应发生率。Objective To investigate the empiric treatment of cefoperazone sulbactam combined with Xuebijing therapy effect of hospitalized elderly patients with pulmonary infection.Methods78hospitalized patients with senile pulmonary infection were enrolled in the hospital from June2016to August2017in the our hospital and were randomly divided into study group(cefoperazone sulbactam empirical therapy plus Xuebijing adjuvant therapy)and control group(cefoperazone sulbactam empirical treatment),39cases in each group.Efficacy of the two groups were compared before and after treatment,inflammation index and the incidence of adverse reactions.Results The efficacy of the study group was significantly higher than that of the control group(P<0.05).Two groups of patients with dizziness,gastrointestinal discomfort,skin rash,liver damage,kidney injury incidence was not statistically significant.Conclusion Given cefoperazone sulbactam for empiric treatment of hospitalized patients with pulmonary infection in the elderly with the conclusion that Xuebijing treatment can significantly improve the clinical efficacy,does not increase incidence and adverse drug reactions.

关 键 词：老年 肺部感染 头孢哌酮舒巴坦 血必净 

分 类 号：R541.6[医药卫生—心血管疾病]